References
- Marmont A, Peschle C, Sanguineti M, Condorelli M. Pure red cell aplasia (PRCA): Response of three patients to cyclopho-sphamide and/or antilymphocyte globulin (ALG) and dem-onstration of two types of serum IgG inhibitors to erythropoiesis. Blood 1975;45:247–261.
- Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: Implications for therapy. Blood 1996;87:4831–4838.
- Childcappa G, Zarrabi MH, Tsan MF. Pure red cell aplasia in patients with chronic lymphocytic leukemia. Medicine (Baltimore) 1986;65:339–351.
- Lacy MQ, Ktu.tin PJ, Tefferi A. Pure red cell aplasia: Association with large granular lymphocyte leukemia and prognostic value of cytogenetic abnormalities. Blood 1996;87: 3000–3006.
- Yasuyama M, Kawauchi K, Takei K, Ogasawara T, Ohkawa S. Pure red cell aplasia occurring during the course of chronic myelogenous leukemia. Rinsho Ketsueki 2004;45:66–71.
- Barosi G, Baraldi A, Cazzola M, Spriano P, Magrini U. Red cell aplasia in myelofibrosis with myeloid metaplasia: A distinct functional and clinical entity. Cancer 1983;52:1290–1296.
- Sarode R, Bambery P, Marwaha N, Gupta A, Garewal G, Deodhar SD. Pure red cell aplasia associated with essential thrombocythemia. Indian J Cancer 1990;27:138–142.
- Geary CG. Drug-related red cell aplasia. Br Med J 1978;1: 51–52.
- Prabhakar SS, Muhlfelder T:. Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Cfin Nephrol 1997;47:331–335.
- Young NS, Mortimer PP. Viruses and bone marrow failure. Blood 1984;63:729–737.
- Sao H, Yashikawa H, Akao Y, Hiraiwa A, Takagi S, Yamauchi T, Yoshikawa S. An adult case of acute erythroblastopenia. Rinsho Ketsueki 1982;(23):1453–1457.
- Orfali KA, Abuakwa YO, Ball SE. Diamond-Blackfan anemia in the UK: Clinical and genetic heterogeneity. Br J Haematol 2004;125:243–252.
- Dessypris EN. The biology of pure red cell aplasia. Semin Hematol 1991;28:275.
- Casadevall N, Cournoyer D, Marsh J, Messner H, Pallister C, Parker-Williams J, Rossert J. Recommendations on haemato-logical criteria for the diagnosis of epoietin-induced pure red cell aplasia. Eur J Haematol 2004;(73):389–396.
- Hirst E, Robertson TI. The syndrome of thymoma and erythroblastopenic anemia. A review of 56 cases including 3 case reports. Medicine 1967;46:225–264.
- Tukic L, Malesevic M, Krstic C, Lakic-Trajkovicz Z, Cik Z. Erythrocyte cell aplasia in chronic myeloid leukemia-coinci-dence or pathogenic link. Med Pregl 1990;43:32–36.
- Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian jj, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P. Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoie-tin. N Engl J Med 2002;346:469–475.
- Alonso Melgar A, Melgosa Hijosa M, Pardo de la Verga R, Garcia Mesegner C, Novarro Torres M. Anti erythropoietin antibodies induced pure red cell aplasia: Post transplant evolution. Pediatric Nephrol 2004;19:1059–1061.
- Gilsanz F, Garcia Vela J, Vargan JA, Ibanez J, Ona F, Lopez J, Roggendorf M. Acquired pure red cell aplasia: A study of six cases. Ann Hematol 1995;(71):181–183.
- Dessypris EN. Pure red cell aplasia. Baltimore: John Hopkins University Press; 1988.
- Mamiya S, Itoh T, Miura AB. Acquired pure red cell aplasia in Japan. Eur J Haematol 1997;59:199–205.
- Bernini JC, Carrillo JM, Buchanan GR. High dose intravenous methylprednisolone therapy for patients with DBA refractory to conventional doses of prednisone. J Pediatrics 1995;(127): 654–659.
- Zeck JV, Todd EP, Dillon M, De Simone P, Utley JR. The role of thymectomy in red cell aplasia. Ann Thorac Surg 1979;28: 257–260.